Japanese Biotech Stock News

TSE:6471
TSE:6471Machinery

Assessing NSK (TSE:6471) Valuation After A Strong 1 Year Share Price Rally

NSK stock performance snapshot NSK (TSE:6471) has caught investor attention after a strong run in the past 3 months and over the past year, prompting a closer look at how its recent returns line up with fundamentals. See our latest analysis for NSK. NSK's recent share price momentum has cooled slightly in the last week after a strong 30 day share price return of 8.1% and a 90 day gain of 31.3%, while the 1 year total shareholder return of 75.3% points to sustained interest in the stock over a...
TSE:2782
TSE:2782Multiline Retail

A Look At Seria (TSE:2782) Valuation After Updated Fiscal 2026 Guidance

Seria (TSE:2782) updated its outlook for the year ending March 2026, guiding to net sales of ¥250,000 million, operating profit of ¥19,300 million, profit of ¥13,000 million and basic EPS of ¥193.80. See our latest analysis for Seria. Seria’s updated guidance comes after a strong recent run in the shares, with a 30 day share price return of 9.20% and a 90 day gain of 25.83%. The 1 year total shareholder return of 47.51% contrasts with more modest year to date share price gains of 8.88%, which...
TSE:9104
TSE:9104Shipping

The Bull Case For Mitsui O.S.K. Lines (TSE:9104) Could Change Following Earnings Upgrade And Energy JV Moves - Learn Why

Mitsui O.S.K. Lines, Ltd. recently reported third-quarter and nine-month results to December 31, 2025, alongside raising its non-consolidated full-year fiscal 2026 guidance, citing stronger assumptions for crude oil tankers, steady vehicle transport demand, and the benefit of suspended U.S. port entry fees. At the same time, the company announced a leadership change effective April 1, 2026, with Representative Director Toshinobu Shinoda retiring from his executive role but remaining on the...